All News about Sanofi-Aventis S.A. ADR
![](https://g.foolcdn.com/editorial/images/749704/doctor-in-consultation-with-a-patient.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
(SNY) - Analyzing Sanofi's Short Interest
October 09, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2019/06/stock-Bristol-Myers-Squibb-08-company.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/06/mrtx_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/10/06/pill-48397_1280.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/10/04/pltr_0.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2022/07/Stock-tevapharmaceuticals-01-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/04/teva.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/10/04/screenshot_2023-10-04_at_5.33.39_pm.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20231003753257/en/739014/5/teva_RGB_JPEG.jpg)
![](https://g.foolcdn.com/editorial/images/749726/doctors-white-coat-healthcare-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/03/airbnbtoronto5.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/10/03/sny.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/10/02/screenshot_2023-10-02_at_6.16.49_pm.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/749166/gettyimages-1199696916.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/28/dnth.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/27/google_search_iphone.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/27/wegovy-company.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/26/screenshot_2023-09-26_at_6.11.54_pm.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/25/pfizer.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/21/darden_-_logo_0.jpg?width=1200&height=800&fit=crop)
Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit
September 21, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/09/21/image45.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/21/gold-image.jpg?width=1200&height=800&fit=crop)
Gold Down Over 1%; FedEx Shares Rise On Earnings Beat
September 21, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/09/21/image34.jpeg?width=1200&height=800&fit=crop)
Nasdaq Down Over 1%; US Initial Jobless Claims Fall More Than Expected
September 21, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/09/21/tvtx.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/20/neuralink_elon_musk_jr_morty_and_jlstock_on_shutterstock.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/20/spry.png?width=1200&height=800&fit=crop)
FDA Rejects EpiPen Alternative - ARS Pharmaceuticals' Allergic Reaction Nasal Spray
September 20, 2023
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.